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Abstract Bronchiectasis is increasingly beingrecognized as an in£ammatorycondition ofthe airways inwhich patho-
logicalpermanentdilation occurs.Wehave obtained endobronchial biopsies in14 patientswith stable bronchiectasis and
15 control subjects. Airway neutrophils, macrophages and tumour necrosis factor-a (TNFa)-positive cellswere stained
withmonoclonal antibodies and the densities of positive cells inthe lamina propriawere determinedbyusinga computer
image analyser.Therewas signi¢cantlyhigherneutrophil, macrophage and TNFa-positive celldensitiesinthelaminapro-
pria of bronchiectatic than control airways (P50?001, P50?001and P=0?0002, respectively).Airwayneutrophil density,
in bronchiectasis but not in controls, correlatedwithTNFa-positive cell density (r=0?71, P=0?004). A signi¢cant correla-
tionbetween airwaymacrophage and TNFa-positive celldensitieswas demonstratedinbothcontrol andbronchiectatic
airways (r=0?63,P=0?016 and r=0?60,P=0?02 respectively).Neutrophildensitynegativelycorrelatedwithpercentforced
vital capacity (FVC%) predicted among patients with bronchiectasis (r=70?53, P=0?04). Bronchiectasis patients who
were regular sputum producers had a signi¢cantly higher macrophage, but not neutrophil density, than their counter-
parts (P=0?02 and P=0?48 respectively). Our original ¢ndings suggest that airway macrophages could contribute to
neutrophil in£ux into airway walls through their production of TNFa and therefore play an important role in the
pathogenesis of bronchiectasis.c 2001Harcourt Publishers Ltd
doi:10.1053/rmed.2001.1155, available online at http://www.idealibrary.comon
Keywords bronchiectasis; neutrophils; macrophages; airway biopsy.INTRODUCTION
Bronchiectasis is a chronic infective and in£ammatory
airway disease with diverse aetiology. The a¡ected air-
ways become tortuous, £abby, permanently dilated and
sometimes partially obstructed by purulent or viscid
exudates (1). Patients with bronchiectasis su¡er from
distressing regular sputum production and recurrent
infection.Neutrophils are themost predominant cells in
the airway lumen in bronchiectasis and they release
enzymes, such as neutrophil elastase, capable of digest-
ing the airwayconnective tissue (2^4).Pro-in£ammatory
cytokines, including tumour necrosis factor-a (TNFa),
interleukin-1 (IL-1) and IL-8, which mediate airway
in¢ltration by neutrophils, are found in abundance in
sputum obtained from bronchiectatic patients (5^7).
Most previous studies on airway in£ammation in
bronchiectasis have focused on the measurement ofReceived 6 March 2001and accepted in revised form 23May 2001
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airway wall in£ammation and cytokine expression are
available in bronchiectasis. Endobronchial biopsy, by
directly sampling the airwaymucosa, is awidely accepted
technique in the investigation of the cellular, immuno-
logical andmolecular abnormalities, cytokine pro¢les, and
airway remodelling in asthma and chronic obstructive
pulmonary disease (COPD) (8^10). However, it is seldom
performed to study airway in£ammation and structural
changes in bronchiectasis (11^13). We have, therefore,
evaluated the cellular in¢ltration in bronchiectatic air-
ways obtained by endobronchial biopsy and determined
the inter-relationship among cellular and clinical
parameters.
METHODS
Subject recruitment
Patients with proven bronchiectasis, diagnosed by high
resolution computed tomography (HRCT), were re-
cruited from the specialist respiratory clinics of the Uni-
versity of Hong Kong with written informed consent.
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unstable systemic diseases; no alteration in medication
and dosage for at least 3 months; ‘steady state’ bronch-
iectasis.The latter was de¢ned as the absence of signi¢-
cant (i.e. 520%) alteration of 24h sputum volume,
forced expiratory volume in1sec (FEV1) and forced vital
capacity (FVC), or changes in respiratory symptoms for
three consecutiveweeks (5). Spirometry (FEV1and FVC),
expressed as per centpredicted,wasmeasuredbetween
10?00 and12?00 hourswith a SensorMedics 2200 (Sensor-
Medics,Yorba Linda,U.S.A.) package.ThoracicHRCTwas
performed, within the previous 12 months, using a
General Electric Hispeed Advantage Scanner to perform
1mm thick sections at10mmintervals in the supine posi-
tion.The number of lung lobes (including lingula) a¡ected
bybronchiectasis, as evidentby thebronchial segmentor
sub-segment being larger than the accompanying artery,
was determined for each patient (14).
Subjects, who were otherwise healthy and free from
known respiratory diseases, that underwent broncho-
scopy for investigation of incidental radiographic discovery
of abnormal unilateral shadow suspicious of bronchial
carcinoma,wererecruitedwithwritteninformedconsent.
Other inclusion criteria included thepresence of comple-
tely normal bronchoscopy, normal lung spirometry and
absence of other systemic diseases or history of smoking
in the previous 3 years. All the procedures and assess-
ment process involved in this study had approval from
the institutional ethics committee.
Bronchoscopy and endobronchial biopsy
(EBB)
All subjects underwent identical and standard broncho-
scopy protocol, without premedications, using Olympus
BFP20 bronchoscopes (Olympus, Tokyo, Japan). EBB
were taken with Olympus FB15 alligator forceps (Olym-
pus). For each patient, two to six EBBs were taken from
the most severely a¡ected bronchiectatic segments, as
determined by HRCT performed less than 12 months
before bronchoscopy. Up to four EBBs were obtained
from the lower lobe basal segments of the radiologically
normal bronchial tree from control subjects.
Immunohistochemistry
EBBs were immediately ¢xed in 10% bu¡ered formalin
prior to embedding in para⁄n. Immunohistological
staining for neutrophils, macrophages and TNFa was
performed usingmonoclonal mouse anti-human antibo-
dies against neutrophil elastase,CD68 and TNFa (Dako,
Glostrup, Denmark for neutrophil elastase and CD68;
Sanbio,Uden,The Netherlands forTNFa), and ampli¢ed
using an avidin^biotinperoxidase complex (ABC)method
(15). Isotype-matched control immunoglobulins (IgG,
Dako) wereused as negative controls. Serial consecutive3mm sectionswere de-para⁄nized in xylene, rehydrated
through graded ethanol solutions, washed with PBS
and treated with 0?12% hydrogen peroxide for 20min
to block endogenous peroxidase activity. This was
followed by pre-incubation with 20% normal horse
serum for 45min to prevent non-speci¢c binding of
immunoglobulins to tissue.The sections were then incu-
bated with primary antibodies (diluted 1: 600 for
neutrophil elastase; 1:100 for CD68; 1: 300 forTNFa in
PBS) at 48C in a moist chamber overnight, and washed
again with PBS. This was followed by incubation with
biotinylated ‘Universal’ antibody, and with Vectastain
Elite ABC reagent (VectaStain Universal Elite ABC Kit,
Vector Laboratories, Inc, Burlingame, CA, U.S.A.)
respectively for 45min. Diaminobenzidine (Vector
Laboratories, Inc. was used as substrate. Slides were
counterstained with haematoxylin and mounted in syn-
thetic mountingmedium.
Quantitation of immunostained cells
Positive staining for neutrophil elastase,CD68, andTNFa
was scored respectively if it was exclusively located
intracellularly (15).Tominimizevariation in interpretation
of the slides, staining for eachmarker frombothpatients
and controls was done in one single experiment.
Slideswere coded and then assessedby a single observer
who was blind to the treatment received by the
specimens.The total number of cells stained positive for
neutrophil^ elastase, CD68 and TNFa in the lamina
propria of EBB sections was counted by using a Leica
Qwin computerized image analyser (Image Analysis,
Cambridge, U.K.) at a ¢nal magni¢cation of 6400.
Results were expressed as number of positive cells
mm71of lamina propria.
Statistical analysis
Results were expressed as median and range unless
otherwise speci¢ed. Comparison between groups was
made non-parametrically by using the Mann^Whitney
rank order test. Correlation was evaluated by Spear-
man’s rank method. A P-value of50?05 was considered
as statistically signi¢cant.
RESULTS
Patient demography and clinical
characteristics
Subject demography and clinical characteristics are
shown inTable 1. Fourteen patients with bronchiectasis
(nine females; mean+SD age: 59+12years) and 15 con-
trol subjects (¢ve females; mean +SD age: 58+13 years)
wererecruitedbetween September1998 and September
1999.Twelve of the patients were non-smokers and two
TABLE 1. Clinical characteristics of subjectswho underwent bronchial biopsies
Parameter Bronchiectasis patients Controls
All (n=7) Regular sputum
(n=7)
Non-regular sputum
(n=7)
(n=15)
Mean age+SD (years) 59+12 63+12 54+10 58+12
Female gender (%) 9 (64?3) 5 (71?4) 4 (57?1) 5 (33?3)
Mean+SDFEV1% predicted 83?8+27?3 80?3+27?8 82?4+26?6 87?8+16?0
Mean+SDFVC % predicted 81?7+25?0 82?86+21?15 79?1+29?1 93?8+12?7
Mean+SD numberof bronchiectatic lunglobes 2?2+0?99 2?2+1?2 2?1+0?9 ö
Median 24 h sputumvolume (range, ml) 15?6 (9?2^25)* 15?6 (9.2^25) ö ö
Medianneutrophilmm72 in lamina propria (range) 608 (101^1013) 691 (222^927) 576 (101^1013) 127 (24^630){
Medianmacrophagemm72 in lamina propria (range) 694 (145^1361) 1038 (655^1361) 638 (145^1051){ 298 (129^856){
MedianTNFa positive cellmm72 in lamina propria (range) 299 (61^654) 335 (157^654) 285 (61^630) 60 (15^322){
*Sputum specimenswere not available in seven patientswith bronchiectasis.Therewas no signi¢cantdi¡erence between age,
gender distribution, and lung function parameters between bronchiectasis patients and control subjects (P40?05).
{P50?05whencomparedwithbronchiectasispatientswithregular sputumproduction; {P50?05whencomparedwithbronch-
iectasis patients.
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ni¢cant di¡erence in age (P=0?90), gender distribution
(P=0?13) or smoking history (P=0?06) between the two
subject groups.Mostpatients hadbilateral bronchiectasis
and the biopsied bronchial segments were right lower
(n=9), left lower (n=2), lingula (n=2) and right middle
lobes (n=1). Seven of the bronchiectatic subjects did not
produce sputum for examination. The remaining seven
had only commensal bacteria on routine microbiological
culture for bacterial pathogens.
Airway neutrophils andmacrophages
There was more intense neutrophil in¢ltration in the
lamina propria of bronchiectatic compared with control
airways [Fig. 1(a), (b)]. The median neutrophil density in
bronchiectatic airway biopsies was signi¢cantly higher
than that in control specimens [P50?001; Table 1; Fig.
2(a)]. Neutrophils were observed predominantly to be
immediately beneath the epithelium, and some were
found within epithelial layer in bronchiectatic specimens
[Fig.1(a)].Neutrophil adhesion to the endotheliumwithin
the lumen of airway capillaries was also observed in
some of the bronchiectatic specimens.
Unlike neutrophils, macrophages appeared to be
evenlydistributed throughout the entirebronchial lamina
propria in both bronchiectatic and control airways
[Fig.1(c), (d)].Macrophage density was signi¢cantly high-
er in the bronchiectasis airway compared with control
(P=0?001; Table 1; Fig. 2(b)]. Bronchiectasis patients who
produce sputum at steady state had a signi¢cantly higher
airway macrophage, but not neutrophil, density com-
paredwith their counterparts who did not produce spu-
tum (Table1;P=0?02 and P=0?48 respectively).AirwayTNFa expression
TNFa was stained by using monoclonal antibody to
humanTNFa onconsecutive sections from the same tissue
blocks used for macrophage and neutrophil elastase
staining assessment. TNFa-positive cell density in
bronchiectatic airways was signi¢cantly higher than in
controls [Figs1(e), (f), 2(c);Table1;P=0?0002]. Bronchiec-
tatic patients who were regular sputum producers did
not have a signi¢cantly di¡erent TNFa-positive cell den-
sity than their counterparts (Table1;P=0?66).
Correlation analysis
A signi¢cantcorrelationwas foundbetweenTNFa-positive
cells and airway neutrophils in bronchiectatic (r=0?71;
P=0?004), but not control airways (r=70?34; P=0?26).
However, in both bronchiectasis and controls, airway
macrophage density correlated with TNFa-positive cell
density signi¢cantly (r=0?63, P=0?02 and r=0?60, P=0?02
respectively).The results of correlation analysis between
the cell counts and some clinical parameters are shown
in Table 2. Among patients with bronchiectasis, airway
neutrophil density showed a negative correlation with
FVC (r=70?53,P=0?04).Therewas, however, no correla-
tion between other clinical parameters with airway
macrophage and TNFa-positive cell densities in lamina
propria.
DISCUSSION
There have been a few human studies which evaluated
airway wall in£ammation in bronchiectasis (11^13). We
FIG. 1. Photomicrographs showing immunostaining of bronchial biopsy specimens with antibody to neutrophil elastase in (a)
bronchiectasis and (b) controls; antibody to CD68 in (c) bronchiectasis and (d) controls; and antibody toTNFa in (e) bronchiectasis
and (f) controls.Each originalmagni¢cation,6400.
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steady state bronchiectasis patients and compared the
quantitative immunohistochemisty ¢ndings with airway
specimens from control subjects. There was signi¢cant
increase in neutrophil and macrophage densities in the
lamina propria of bronchiectatic compared with control
airways. There was a signi¢cantly higher numbers of
TNFa-positive cells in bronchiectatic airways compared
with controls.Further analysis revealed a correlation be-tweenTNFa-positive cell and airway neutrophil densities
in the bronchiectatic airways, which has not been re-
ported previously. There was also a positive correlation
between airwayTNFa-positive cell andmacrophage den-
sities in both bronchiectasis and control subjects. A
signi¢cantnegative correlationwas foundbetween airway
neutrophil density and FVC%predictedvalue among the
patients with bronchiectasis. However, there was no
signi¢cant correlation between clinical parameters of
FIG. 2. Dot plots showing the comparisons of (a) neutrophil,
(b) macrophage and (c) TNFa-positive cell densities in bronchial
biopsy specimensbetween control andbronchiectatic subjects.
TABLE 2. Correlation betweenmarkers of disease severity an
FEV1
% predicte
r (P)
Neutrophilsmm72 of lamina propria 70?37 (0?1
Macrophagesmm72 of lamina propria 0?11 (0?71
TNFa+ cellsmm72 of lamina propria 70?08 (0?4
Data shown are Spearman’s rankcorrelation coe⁄cients.
Valueswith P50?05 are in bold.
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dicted, number of lung lobes a¡ected by bronchiectasis,
with airway macrophage orTNFa-positive cell densities
in bronchiectasis. Although bronchiectasis patient who
had regular sputum production had a signi¢cantly higher
macrophage density in their airway lamina propria than
their counterparts, there was no such di¡erence in the
airway neutrophil and TNFa-positive cell densities.
Although the aetiology of bronchiectasis is diverse,
the net result is pathogenic destruction of airway archi-
tecture, which facilitates airway bacterial colonization,
infection and pooling of secretion (16,17). However, un-
like the case in asthma and COPD (8^10), little is known
about the pathogenesis particularly, the in£ammatory
aspects of airway wall in bronchiectasis (11^13).Our data
showed thatextensiveneutrophilic andmacrophage in¢l-
tration exists in bronchiectatic airways.We have further
shown, for the ¢rst time, that there was a negative cor-
relation between airway neutrophil density and lung
function in bronchiectasis (Table 2).This correlation has
also been recently reported in chronic bronchitis (9),
another airway disorder also increasingly recognized as
an in£ammatory disease (8^10).
Airway immunohistochemical studies in bronchiecta-
sis revealed that increased airway in¢ltration with neu-
trophils, T-lymphocytes, macrophages and IL-8-positive
cells occurs in bronchiectasis (11^13). However, possibly
due to theretrospectivenature of some of these studies,
the clinical relevance of these ¢ndings remains unex-
plored. Our study is therefore the only immunohisto-
chemical study on bronchiectatic airways, which
also takes account of concomitant clinical parameters
including lung function parameters and extent of
bronchiectasis.
Macrophages, unlike neutrophils, are constitutively
present in the normal lung. Our results showed that
macrophage density in lamina propria of bronchiectatic
airways was more than double that in control airways.
This indicates that increasedmonocyte recruitment into
the airway also occurs in bronchiectasis. Macrophages/
monocytes are the predominant source of TNFa within
the body, and their expression of TNFa in the form of
protein and mRNA, is readily induced by the presence
of bacterial endotoxins such as lipopolysaccharide (LPS)d airwaywall in£ammation in bronchiectasis
d
FVC
% predicted
r (P)
No. of lobes
with bronchiectasis
r (P)
2) 70?53 (0?04) 70?02 (0?94)
) 0?03 (0?93) 70?18 (0?56)
0) 70?25 (0?22) 70?17 (0?57)
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respiratory pathogens such asHaemophilus in£uenzae and
Pseudomonas aeruginosa in their lower respiratory tract,
and the LPS from these pathogens could, therefore, act
as a potent stimulus for the production of TNFa by
macrophages. Our data, by showing a correlation be-
tweenTNFa-positive cells with macrophages in bronch-
iectatic airways, suggest that airway macrophages
couldbe amajor source of airwayTNFa. Sputumproduc-
tion re£ects disease activity in bronchiectasis and our
patients with bronchiectasis who had regular sputum
production had a signi¢cantly highermacrophagedensity
than the non-producers. This suggests that airway
macrophages could be related to disease activity in
bronchiectasis. However, there was no direct correla-
tion between airway macrophage density with clinical
parameters. The positive correlation between airway
neutrophil density and TNFa expression, demonstrated
by our study, suggests that macrophages accumulation
in the bronchiectatic airways could be implicated in neu-
trophil recruitment viaTNFa production.
TNFa is strongly chemotactic and degranulating for
neutrophils (20^23), and is found in abundance in the
sputum and bronchoalveolar lavage £uid from patients
with bronchiectasis and cystic ¢brosis (5^7,24,25). Our
results showed, for the ¢rst time, the upregulation
of TNFa expression in bronchiectatic airways and its
positive correlationwith airwayneutrophil densityin vivo.
The exactrole of TNFa in thepathogenesis of bronchiec-
tasis is uncertain, butcould include induction of endothe-
lial and leukocyte adhesionmolecules, such as E-selectin,
ICAM-1andCD11/CD18 (20,26), enhancementof vascular
permeability of airway vasculature (20), release of neu-
trophils from bone marrow into the circulation (20,27),
and upregulation of neutrophil release of toxic oxygen
radicals and lysosomal enzymes (28).Our ¢ndings of up-
regulation of TNFa expression inbronchiectatic airways,
which correlated with airway neutrophil density,
strongly suggest an importantrole of TNFa in neutrophil
recruitment into the airways in bronchiectasis.
Our prospective study showed an increase in macro-
phage, neutrophil and TNFa-positive cell densities in the
lamina propria of bronchiectatic when compared with
control airways. The positive correlation between
macrophage and TNFa-positive cell densities, and the
correlation between the latter and neutrophil density in
the bronchiectatic airway suggest that macrophage ac-
cumulation could contribute to, via production of TNFa,
neutrophil in¢ltration in bronchiectasis.These recruited
neutrophils could in turn lead to airway damage as re-
£ected by the negative correlation between neutrophil
density and FVC % predicted value. This would also be
consistent with our recent ¢nding that sputum neutro-
phil elastase, but not pro-in£ammatory mediator levels,
correlated with clinical parameters of disease activity in
bronchiectasis (29).ACKNOWLEDGEMENTS
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